BRITTANY SIMPSON: Open Payments
NPI 1841857810 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 7 payments from 5 companies in 2025. Trend: 2023 $489 · 2024 $365 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $169 |
| Kowa Pharmaceuticals America, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
| Syndax Pharmaceuticals, Inc. | 1 | $14 |
Products named: FARXIGA, ZORYVE, REXULTI, QULIPTA.
Industry payments across KS — which companies pay providers there.
